Cargando…
COVID-19-associated coagulopathy and disseminated intravascular coagulation
The pathology of coronavirus disease 2019 (COVID-19) is exacerbated by the progression of thrombosis, and disseminated intravascular coagulation (DIC), and cytokine storms. The most frequently reported coagulation/fibrinolytic abnormality in COVID-19 is the increase in d-dimer, and its relationship...
Autores principales: | Asakura, Hidesaku, Ogawa, Haruhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648664/ https://www.ncbi.nlm.nih.gov/pubmed/33161508 http://dx.doi.org/10.1007/s12185-020-03029-y |
Ejemplares similares
-
Diversity of disseminated intravascular coagulation and selection of appropriate treatments
por: Asakura, Hidesaku
Publicado: (2020) -
Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation
por: Takahashi, Wakana, et al.
Publicado: (2021) -
Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm
por: Yamada, Shinya, et al.
Publicado: (2022) -
Classifying types of disseminated intravascular coagulation: clinical and animal models
por: Asakura, Hidesaku
Publicado: (2014) -
COVID-19 coagulopathy: is it disseminated intravascular coagulation?
por: Levi, Marcel, et al.
Publicado: (2020)